Compare DexCom, Inc. (DXCM) vs nVent Electric (NVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs nVent Electric — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while nVent Electric trades at $167.43 (market cap $26.58B). The key difference: DexCom, Inc. is the larger of the two by market cap, and nVent Electric pays a 0.51% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and nVent Electric for 11 Days on average.
| DXCM | NVT | |
|---|---|---|
Market Cap | $31.86B | $26.58B |
Volume | 3,607,070 | 2,520,678 |
Sector | Health | Industrials |
52-Week High | $92.34 | $184.34 |
52-Week Low | $54.84 | $94.99 |
Typical Hold Time | 62 Days | 11 Days |
Enterprise Value | $31.32B | $27.95B |
Dividend Yield | — | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About nVent Electric
nVent provides electrical connection and protection solutions, including enclosures, fastening systems, and thermal management products. Its products help support electrical and industrial infrastructure across multiple end markets.
Read more on NVT →
